Is BMY or CI cheaper?

On trailing earnings, CI is cheaper: BMY trades at a 16.05 P/E and CI at 12.64.

Which has grown faster, BMY or CI?

Over the past five years, CI grew revenue faster — BMY at a 2.52% CAGR versus CI at 11.28%.

Does BMY or CI pay a bigger dividend?

BMY yields 4.38% and CI yields 2.06% based on trailing dividends and the latest price.

Is BMY or CI more profitable?

BMY runs the higher net margin — BMY at 15.01% versus CI at 2.26%.

Which has been the better investment, BMY or CI?

Over the past 10-year, CI delivered the higher annualized total return — BMY at 1.08% versus CI at 9.91%. Past performance doesn't predict future results.

Bristol-Myers Squibb Company (BMY) vs Cigna Corporation (CI)

CI leads on 9 of 17 compared metrics.

A side-by-side comparison of Bristol-Myers Squibb Company and Cigna Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

BMY

Bristol-Myers Squibb Company

Total return — BMY vs CI

growth of $100 · last 30y

BMY +171.1%CI +2316.9%CI compounded faster

Log scale — wide-divergence pair

BMY CI

BMY vs CI: by the numbers

•BMY is the larger company ($116.66B vs $78.83B market cap).
•CI trades at the lower earnings multiple (12.64 vs 16.05 P/E).
•BMY converts more revenue to profit (15.01% vs 2.26% net margin).
•CI grew revenue faster over the past five years (11.28% vs 2.52% CAGR).
•BMY pays the higher dividend yield (4.38% vs 2.06%).

Which is better, BMY or CI?

Metric tally: BMY 8 · CI 9

It depends on what you're optimizing for:

ValueCI(lower P/E)

GrowthCI(faster 5Y revenue CAGR)

IncomeBMY(higher dividend yield)

QualityBMY(higher ROIC)

Metrics side by side

Valuation

Metric	BMY	CI
P/E ratio	16.05	12.64●
Forward P/E	9.31	8.91●
P/S ratio	2.41	0.28●
P/B ratio	5.82	1.87●
PEG ratio	1.71	0.15●
EV / EBITDA	11.03	8.41●
FCF yield	10.20%●	9.73%

Profitability

Metric	BMY	CI
Gross margin	68.75%●	9.30%
Operating margin	25.67%●	3.42%
Net margin	15.01%●	2.26%
ROE	36.25%●	14.90%
ROIC	13.90%●	7.35%

Dividends

Metric	BMY	CI
Dividend yield	4.38%●	2.06%
Payout ratio	72.25%	27.53%

Growth (annualized)

Metric	BMY	CI
Revenue CAGR (5Y)	2.52%	11.28%●
EPS CAGR (5Y)	9.38%●	-0.76%
FCF CAGR (5Y)	-2.50%	-2.03%●
Total return CAGR (5Y)	0.74%	6.19%●

Frequently asked

Which is better, BMY or CI?: It depends on your goal. value: CI (lower P/E); growth: CI (faster 5Y revenue CAGR); income: BMY (higher dividend yield); quality: BMY (higher ROIC). Across all compared metrics, CI leads 9 to 8.
Is BMY or CI cheaper?: On trailing earnings, CI is cheaper: BMY trades at a 16.05 P/E and CI at 12.64.
Which has grown faster, BMY or CI?: Over the past five years, CI grew revenue faster — BMY at a 2.52% CAGR versus CI at 11.28%.
Does BMY or CI pay a bigger dividend?: BMY yields 4.38% and CI yields 2.06% based on trailing dividends and the latest price.
Is BMY or CI more profitable?: BMY runs the higher net margin — BMY at 15.01% versus CI at 2.26%.
Which has been the better investment, BMY or CI?: Over the past 10-year, CI delivered the higher annualized total return — BMY at 1.08% versus CI at 9.91%. Past performance doesn't predict future results.

Go deeper

Full BMY analysis Full CI analysis Interactive comparison tool

Dig into the metrics

Bristol-Myers Squibb P/E ratio Cigna P/E ratio Bristol-Myers Squibb dividend yield Cigna dividend yield Bristol-Myers Squibb ROE Cigna ROE Bristol-Myers Squibb operating margin Cigna operating margin Bristol-Myers Squibb revenue growth Cigna revenue growth Bristol-Myers Squibb free cash flow Cigna free cash flow

Bristol-Myers Squibb & Cigna appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.